Ketoflip 10mg Tablet DT contains Ketorolac tromethamine, a potent nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. Each tablet delivers 10mg of Ketorolac, indicated for the short-term management of moderate to severe acute pain, including postoperative pain, musculoskeletal injuries, and dental pain. Ketorolac exerts its effect by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever. The orally disintegrating tablet (DT) formulation facilitates rapid disintegration and absorption, enhancing patient compliance, especially in individuals with difficulty swallowing conventional tablets. Ketoflip 10mg should be administered at the lowest effective dose for the shortest duration to minimize the risk of adverse effects such as gastrointestinal irritation, bleeding, renal impairment, and cardiovascular events. It is contraindicated in patients with active peptic ulcer disease, recent gastrointestinal bleeding, severe renal or hepatic impairment, and known hypersensitivity to NSAIDs. Caution is advised in elderly patients and those with a history of cardiovascular disease or asthma. Ketoflip 10mg Tablet DT is intended for short-term use, generally not exceeding five days, and should be used under medical supervision with appropriate monitoring of renal function and gastrointestinal tolerance.